After Encountering ‘Issues’ With Other Compounding Pharmacies, OSRX® Has Become an Integral Part of My Practice

By Jacqueline D. Griffiths, MD

Dr. Jacqueline D. Griffiths began performing laser vision correction practically from its inception. This board-certified ophthalmologist opened the first and only Laser Eye Center in Reston, Virginia in 1999.  Today, her combined comprehensive ophthalmology practice and laser center specializes in the latest advances in cataract and refractive surgery and is one of a handful of women- and minority-owned laser centers in the world.  Dr. Griffiths has repeatedly been voted “Top Ophthalmologist” by the Washington Post, Northern Virginia Magazine and the Washingtonian Magazine.

I previously used compounding drops from two different compounding pharmacies before I was introduced to OSRX®. Let’s just say there were some challenges of reliability filling prescriptions and a few other issues before my OSRX discovery. 

I did, however, like the concept of compounding pharmacies, so I did some homework and ran across an OSRX article by Nicole Fram, MD, which led me to call the company for more information. My local OSRX rep came to see me in Virginia, and I’ve appreciated the relationship ever since.

I find OSRX to have the best customer service and the best formulations. My patients and staff no longer have challenges with pharmacies, insurance and multiple drop regimens. OSRX is now an integral part of my practice.

Saving time is vital for my practice. As a one-stop shop, where we provide new technologies, implants and other advancements that demand thorough pre- and post-op instructions, prescribing (OMNI by OSRX®) is a cinch. It’s the easiest item to discuss with my patients. Having only one bottle to keep up with, reasonable pricing and a very simple regimen enables my patients to be more compliant. I also like the simplicity of ordering the drops through my Electronic Prescribing System.

Click Here to Request an OSRX Price Quote

We primarily prescribe the Prednisolone, Moxifloxacin and Bromfenac compounded formulations (also known as OMNI drops) for cataract patients. I have noted how quiet the eyes are at the one week visit.   It’s truly a win-win for both my patients and my staff in terms of compliance, price, reliability and excellent customer service.  

We also appreciate the OSRX prescriber portal. My technician checks the delivery status about a week before surgery and that’s it. In fact, I hope to branch into using OSRX drops for refractive surgery. The challenge has been that many of my patients want prompt surgery, and I don’t always trust the Post Office to be timely, but I love the OSRX compounded formulation and the affordability for my patients.

My patients are obviously my foremost priority, so my staff created a simple form to explain why compounded drops are preferable. When I transitioned from individual drops to compounding, some longtime patients raved how much better and affordable the new drops were and asked why I hadn’t prescribed them before. 

Another invaluable time-saver involves insurance. Handling different types of patient coverage used to be a nightmare when dealing with individual drops. (Although compounded drops are generally not covered by insurance, I find that they are still less costly than most copays for other drops.) We were constantly on the phone, changing instruction forms and dates to assure our patients took the right amounts of drops at the right times. Now with OMNI drops, we’re on a simple three times a day for two weeks plan, which tapers during the final two weeks. It’s all done in a month and is so easy for patients to follow.  

As my practice continues to get busier, especially with Baby Boomers reaching the critical age for cataract surgery, I just don’t have time to go through multiple regimens, callbacks, dealing with pharmacies and other time-grabs.  

People like to reminisce about the good old days, but from an eye drop perspective, I’m never going back to the way it used to be. 



Professional Disclosure: Dr. Griffiths is a medical advisory board member for Ocular Science® (an OSRX affiliate) and has a financial interest in the company.

OSRX operates in full compliance with Section 503A regarding compounded drugs as defined in the FD&C Act.

*Compounded medications are generally not reviewed by the FDA for safety or efficacy. OSRX does not compound copies of commercially available products. References available upon request.

Click here to view potential contraindications.